What’s Next For Gene Therapy? Plastics Researchers Design Polymer Macromolecules As Gene Transfer Agents
Gene therapy depends upon foreign DNA, even viruses, to deliver genes, therapeutic proteins, or medicine to cells within the body. Many scientists are looking for better chaperones across the cell membrane. Virginia Tech researchers think polymer molecules can be created to do the job.
Chemistry Paves Way Toward Promising Stem Cell Therapies
Chemists are developing new insights and techniques in an effort to expand the therapeutic potential of stem cells, which includes possible treatments for Parkinson’s disease, diabetes, spinal cord injury and other devastating conditions.
Adult Stem Cell in Blood Used to Make Neurons
Researchers say they were able to isolate a rare type of adult stem cell that circulates in the blood and convert the stem cells into neurons, bone cells, fat cells and two kinds of blood vessel cells.
University of Florida Study Shows Leptin Could Combat Type 2 Diabetes
Using a novel gene therapy technique, UF researchers were able to reverse type 2 diabetes in mice.
Advanced Cell Technology Reports Visual Function Rescue in Animals Utilizing Human Embryonic Stem Cell-Derived Retinal Cells
Advanced Cell Technology, Inc. announced that company scientists and their collaborators rescued visual function in rats through implantation of retinal pigment epithelial cells (RPE) derived from human embryonic stem (hES) cells.
Gene Therapy Zeroes in on Brain Cancer Tumors
Researchers in Saginaw Township and Illinois are eager to begin, by spring, the first human tests of a revolutionary gene-based brain cancer therapy.
Stem Cell Trials Show Sustained Heart Function Improvement
Australian adult stem cell company, Mesoblast Limited, announced positive initial results of clinical adult stem cell trials for the treatment of heart disease being conducted in conjunction with its United States-based sister company Angioblast Systems Inc.
Stem Cell Trial for Neurodegenerative Pediatric Disease to Get Under Way
A phase I trial to test the safety of stem cell transplants to treat Batten disease, a rare yet fatal neurodegenerative disorder, is about to get started at Oregon Health & Science University’s Doernbecher Children’s Hospital.
Man Rejects First Penis Transplant
Surgeons in China who said they performed the first successful penis transplant had to remove the donated organ because of the severe psychological problems it caused to the recipient and his wife.
Immature Cells Strengthen Damaged Heart
Injecting immature cells into hearts damaged months or years earlier by a heart attack can help that heart beat more efficiently.
‘Stolen Bone’ Hospitals Revealed
Health watchdogs have named 25 UK hospitals which have bought potentially contaminated body parts allegedly stolen in the US.
Cloning Scientist Hwang Failed to Notice Forged Research, Researcher Says at Trial
A researcher accused of fabricating data for scientist Hwang Woo-suk’s now-discredited stem cell research claimed Tuesday that Hwang’s negligence in detecting the faked results enabled him to repeatedly forge scientific evidence.
National Stem Cell Bank Announces Addition of New Cell Lines
The National Stem Cell Bank has expanded its offering of human embryonic stem cell lines to include cells from the University of California, San Francisco (UCSF).
U.K. Stem Cell Bank to Release First Embryo Cells to Researchers
U.K. scientists today are expected to decide to allow researchers access to embryonic stem cells in the Medical Research Council’s three-year-old bank. The National Institute for Biological Standards and Control is expected to confirm that six kinds of embryonic stem cells are ready for release to U.K. researchers, with others types to follow.
ABSTRACTS, REVIEWS & SPECIAL REPORTS
Derivation of Human Embryonic Stem Cells from Developing and Arrested Embryos
This research demonstrates that arrested embryos are additional valuable resources to surplus and donated developing embryos and should be used to study early human development or derive pluripotent hESC.